Selecta Biosciences, Inc. Profile Avatar - Palmy Investing

Selecta Biosciences, Inc.

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program …

Biotechnology
US, Watertown [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Selecta Biosciences, Inc. has no acquisition track records yet.

M&A Deals · History

Selecta Biosciences, Inc. has no acquisition track records yet.

End of SELB's Analysis
CIK: 1453687 CUSIP: 816212104 ISIN: US8162121045 LEI: - UEI: -
Secondary Listings
SELB has no secondary listings inside our databases.